ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC
BSE5295.00-24.75 (-0.47 %)
PREV CLOSE ( ) 5319.75
OPEN PRICE ( ) 5329.95
BID PRICE (QTY) 5294.60 (2)
OFFER PRICE (QTY) 5312.55 (2)
VOLUME 696
TODAY'S LOW / HIGH ( )5267.55 5377.10
52 WK LOW / HIGH ( )3102 7208
NSE5299.95-14.8 (-0.28 %)
PREV CLOSE( ) 5314.75
OPEN PRICE ( ) 5329.80
BID PRICE (QTY) 5300.25 (1)
OFFER PRICE (QTY) 5308.55 (2)
VOLUME 5123
TODAY'S LOW / HIGH( ) 5261.00 5380.00
52 WK LOW / HIGH ( )3098 7220.95
Exchange
Year Open Price () High Price () Low Price () Close Price () Volume (000's) Value (lakhs)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.